JP2017532633A5 - - Google Patents

Download PDF

Info

Publication number
JP2017532633A5
JP2017532633A5 JP2017507867A JP2017507867A JP2017532633A5 JP 2017532633 A5 JP2017532633 A5 JP 2017532633A5 JP 2017507867 A JP2017507867 A JP 2017507867A JP 2017507867 A JP2017507867 A JP 2017507867A JP 2017532633 A5 JP2017532633 A5 JP 2017532633A5
Authority
JP
Japan
Prior art keywords
likelihood
predetermined threshold
distance
program instructions
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017507867A
Other languages
English (en)
Japanese (ja)
Other versions
JP6661607B2 (ja
JP2017532633A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2015/050823 external-priority patent/WO2016024278A1/en
Publication of JP2017532633A publication Critical patent/JP2017532633A/ja
Publication of JP2017532633A5 publication Critical patent/JP2017532633A5/ja
Application granted granted Critical
Publication of JP6661607B2 publication Critical patent/JP6661607B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017507867A 2014-08-14 2015-08-12 多様体および超平面を用いる生物学的データのコンピュータ分析 Active JP6661607B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462037180P 2014-08-14 2014-08-14
US62/037,180 2014-08-14
US201562105938P 2015-01-21 2015-01-21
US62/105,938 2015-01-21
PCT/IL2015/050823 WO2016024278A1 (en) 2014-08-14 2015-08-12 Computational analysis of biological data using manifold and a hyperplane

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020021606A Division JP7095001B2 (ja) 2014-08-14 2020-02-12 多様体および超平面を用いる生物学的データのコンピュータ分析

Publications (3)

Publication Number Publication Date
JP2017532633A JP2017532633A (ja) 2017-11-02
JP2017532633A5 true JP2017532633A5 (https=) 2018-07-26
JP6661607B2 JP6661607B2 (ja) 2020-03-11

Family

ID=55303939

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017507867A Active JP6661607B2 (ja) 2014-08-14 2015-08-12 多様体および超平面を用いる生物学的データのコンピュータ分析
JP2020021606A Active JP7095001B2 (ja) 2014-08-14 2020-02-12 多様体および超平面を用いる生物学的データのコンピュータ分析

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020021606A Active JP7095001B2 (ja) 2014-08-14 2020-02-12 多様体および超平面を用いる生物学的データのコンピュータ分析

Country Status (12)

Country Link
US (6) US10303846B2 (https=)
EP (2) EP3699930B1 (https=)
JP (2) JP6661607B2 (https=)
KR (1) KR20170041907A (https=)
CN (2) CN107076746B (https=)
AU (2) AU2015302870B2 (https=)
BR (1) BR112017002884A2 (https=)
CA (2) CA2954601C (https=)
IL (1) IL250585B (https=)
RU (1) RU2730836C2 (https=)
WO (1) WO2016024278A1 (https=)
ZA (1) ZA201700939B (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9709565B2 (en) 2010-04-21 2017-07-18 Memed Diagnostics Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
EP3367099B1 (en) * 2012-02-09 2021-05-26 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
BR112017002884A2 (pt) 2014-08-14 2018-01-30 Memed Diagnostics Ltd ?análise computacional de dados biológicos por meio do uso de variedade e hiperplano?
US20170234873A1 (en) 2014-10-14 2017-08-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
CN111624345A (zh) 2014-12-11 2020-09-04 米密德诊断学有限公司 用于诊断多种感染的标记组合及其使用方法
WO2016145423A1 (en) * 2015-03-11 2016-09-15 Ayasdi, Inc. Systems and methods for predicting outcomes using a prediction learning model
EP3414716A1 (en) * 2016-02-12 2018-12-19 Carrier Corporation Shelf life estimation system
EP3423590A4 (en) 2016-03-03 2020-02-26 Memed Diagnostics Ltd. DETERMINANTS OF RNA TO DIFFERENTIATE BACTERIAL VIRAL INFECTIONS
IL287757B (en) 2016-03-03 2022-07-01 Memed Diagnostics Ltd Analyzing rna for diagnosing infection type
WO2017221255A1 (en) 2016-06-23 2017-12-28 Memed Diagnostics Ltd. Measuring trail by lateral flow immunoassay
EP3482201B1 (en) 2016-07-10 2022-12-14 Memed Diagnostics Ltd. Early diagnosis of infections
EP3482200B1 (en) 2016-07-10 2022-05-04 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
US12205677B2 (en) * 2016-08-10 2025-01-21 Memed Diagnostics Ltd. System and method for analysis of biological data
KR101739703B1 (ko) * 2016-09-13 2017-05-24 (주) 어드밴스드 엔티 Trail 기반 뇌염 감별진단 방법 및 장치
WO2018060999A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of risk assessment and disease classification
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
EP3568864B1 (en) 2017-01-11 2025-07-02 Koninklijke Philips N.V. Method and system for automated inclusion or exclusion criteria detection
CN110520887A (zh) * 2017-02-17 2019-11-29 气象预报公司 用于使用天气数据的统计分析预测经济趋势的系统和方法
WO2018167921A1 (ja) * 2017-03-16 2018-09-20 三菱電機株式会社 信号処理装置
US10209260B2 (en) 2017-07-05 2019-02-19 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
US10474681B1 (en) * 2017-09-26 2019-11-12 Microsoft Technology Licensing, Llc Filtering mapped datasets
US11908581B2 (en) 2018-04-10 2024-02-20 Hill-Rom Services, Inc. Patient risk assessment based on data from multiple sources in a healthcare facility
US11504071B2 (en) * 2018-04-10 2022-11-22 Hill-Rom Services, Inc. Patient risk assessment based on data from multiple sources in a healthcare facility
WO2020036571A1 (en) 2018-08-16 2020-02-20 RICHARDSON, Paul, Stephen Systems and methods for automatic bias monitoring of cohort models and un-deployment of biased models
TW202018727A (zh) 2018-11-09 2020-05-16 財團法人工業技術研究院 整體式學習預測方法與系統
FR3088652A1 (fr) * 2018-11-21 2020-05-22 Nanotracks Diagnostics Détection in vitro de la présence d’au moins un agent pathogène microbien dans un échantillon biologique
AU2020223826A1 (en) * 2019-02-18 2021-08-05 The University Of Liverpool Method of diagnosis
JP7550160B2 (ja) * 2019-03-12 2024-09-12 ノバルティス アーゲー Copdから喘息を区別するためのデジタル解決策
US11104946B2 (en) 2019-04-23 2021-08-31 Inflammatix, Inc. DNA sequences related to diagnosis and treatment of systemic inflammatory response syndrome
US11238129B2 (en) * 2019-12-11 2022-02-01 International Business Machines Corporation Root cause analysis using Granger causality
IL295179A (en) 2020-01-29 2022-09-01 Memed Diagnostics Ltd Methods for diagnosis and classification of viral infections
CN111816297A (zh) * 2020-03-31 2020-10-23 复旦大学附属中山医院 一种基于云端的nCoV病毒诊疗系统和方法
WO2022004730A1 (ja) * 2020-06-30 2022-01-06 株式会社堀場製作所 体液分析装置、体液検体を判定するための方法、および、コンピュータープログラム
CN111657961B (zh) * 2020-07-03 2021-04-27 北京印刷学院 一种在皮肤上制备超表面用于血糖检测的方法
JP2023145811A (ja) * 2020-08-17 2023-10-12 孝章 赤池 学習モデルの生成方法、プログラム、演算装置
CN112185583B (zh) * 2020-10-14 2022-05-31 天津之以科技有限公司 一种基于贝叶斯网络的数据挖掘检疫方法
US11430575B2 (en) * 2020-11-13 2022-08-30 Specialty Diagnostic (SDI) Laboratories, Inc. Systems and methods for a data driven disease test result prediction
CN112632151B (zh) * 2020-12-25 2023-02-10 南京邮电大学 一种基于二分过滤的移动对象传染行为挖掘方法
US11361847B1 (en) 2021-02-06 2022-06-14 Timothy A. Hodge System and method for rapidly reporting testing results
CA3227382A1 (en) * 2021-08-17 2023-02-23 Ephraim L. TSALIK Methods for characterizing infections and methods for developing tests for the same
CN114818833A (zh) * 2022-05-27 2022-07-29 北京市商汤科技开发有限公司 心率测量方法、装置、电子设备、存储介质和程序产品
WO2025015221A1 (en) * 2023-07-12 2025-01-16 Bukowski Radek Interactive platform for assisting with medical decision-making
CN120689546B (zh) * 2025-05-07 2026-02-06 中国科学院空间应用工程与技术中心 一种基于点阵结构的三维建模方法及系统

Family Cites Families (167)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4230767A (en) 1978-02-08 1980-10-28 Toyo Boseki Kabushiki Kaisha Heat sealable laminated propylene polymer packaging material
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4233402A (en) 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4727022A (en) 1984-03-14 1988-02-23 Syntex (U.S.A.) Inc. Methods for modulating ligand-receptor interactions and their application
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5018067A (en) 1987-01-12 1991-05-21 Iameter Incorporated Apparatus and method for improved estimation of health resource consumption through use of diagnostic and/or procedure grouping and severity of illness indicators
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
DE4322330A1 (de) 1992-08-31 1994-03-03 Behringwerke Ag Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
DE4227454C1 (de) 1992-08-19 1994-02-03 Henning Berlin Gmbh Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens
US6283761B1 (en) 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
SE9401351D0 (sv) 1994-04-21 1994-04-21 Venge A method for diagnosis
US5910421A (en) 1995-12-21 1999-06-08 University Of Florida Rapid diagnostic method for distinguishing allergies and infections
US6077665A (en) 1996-05-07 2000-06-20 The Board Of Trustees Of The Leland Stanford Junior University Rapid assay for infection in neonates
US7026446B1 (en) 1997-12-24 2006-04-11 Diatech Pty Ltd. Bifunctional molecules
AU762756B2 (en) 1998-05-18 2003-07-03 Apoptosis Technology, Inc. Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
DE19847690A1 (de) 1998-10-15 2000-04-20 Brahms Diagnostica Gmbh Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
US6709855B1 (en) 1998-12-18 2004-03-23 Scios, Inc. Methods for detection and use of differentially expressed genes in disease states
AU1853600A (en) 1999-01-06 2000-07-24 Choong-Chin Liew Method for the detection of gene transcripts in blood and uses thereof
US6635461B1 (en) 1999-08-24 2003-10-21 Glycozym Aps UDP-N-acetylglucosamine: galactose-β1, 3-N-acetylgalactosamine-α-R/(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3
IL132687A0 (en) * 1999-11-01 2001-03-19 Keren Mechkarim Ichilov Pnimit System and method for evaluating body fluid samples
US20020038227A1 (en) 2000-02-25 2002-03-28 Fey Christopher T. Method for centralized health data management
US7668661B2 (en) 2000-04-28 2010-02-23 Siemens Healthcare Diagnostics Inc. Liver disease-related methods and systems
US20020059030A1 (en) * 2000-07-17 2002-05-16 Otworth Michael J. Method and apparatus for the processing of remotely collected electronic information characterizing properties of biological entities
US20020055176A1 (en) * 2000-11-08 2002-05-09 Ray Robert A. Diagnostic assay system
CN1286985C (zh) 2001-03-27 2006-11-29 株式会社东芝 与疾病相关的核酸
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
DE10119804A1 (de) 2001-04-23 2002-10-24 Brahms Ag Entzündungsspezifische Peptide und deren Verwendungen
AU2002256895B2 (en) * 2001-05-18 2008-09-18 Kirin Beer Kabushiki Kaisha Anti-TRAIL-R antibodies
FI115165B (fi) 2001-06-04 2005-03-15 Aboatech Ab Oy Menetelmä infektion laadun määrittämiseksi
DE10130985B4 (de) 2001-06-27 2004-03-18 B.R.A.H.M.S Ag Verfahren zur Diagnose von Sepsis und schweren Infektionen unter Bestimmung löslicher Cytokeratin-1-Fragmente
US20040209307A1 (en) 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
EP1318407B1 (de) 2001-12-07 2004-09-29 B.R.A.H.M.S Aktiengesellschaft Verwendungen der Aldose-1-Epimerase (Mutarotase) für die Diagnose von Entzündungserkrankungen und Sepsis
DE60207183T2 (de) 2001-12-10 2006-08-10 Kabushiki Gaisha K-And-S Vorrichtung zur Beobachtung biologischer Daten
US20040038201A1 (en) 2002-01-22 2004-02-26 Whitehead Institute For Biomedical Research Diagnostic and therapeutic applications for biomarkers of infection
US7468032B2 (en) 2002-12-18 2008-12-23 Cardiac Pacemakers, Inc. Advanced patient management for identifying, displaying and assisting with correlating health-related data
US20040122296A1 (en) 2002-12-18 2004-06-24 John Hatlestad Advanced patient management for triaging health-related data
AU2003221157A1 (en) 2002-03-22 2003-10-08 Kyowa Medex Co., Ltd. Method of judging viral infection
US7485298B2 (en) 2002-05-23 2009-02-03 Michael Powell Diagnosis and treatment of human dormancy-related sequellae
CA2488632A1 (en) 2002-06-11 2003-12-18 Idaho Research Foundation Type i interferon-inducible proteins to detect viral infection
EP1601947A2 (en) * 2002-10-31 2005-12-07 Health Research, Incorporated Diagnostic test for west nile virus
US8563476B2 (en) 2002-11-15 2013-10-22 Morehouse School Of Medicine Anti-CXCL9, anti-CXCL10, anti-CXCL11, anti-CXCL13, anti-CXCR3 and anti-CXCR5 agents for inflammatory disorders
WO2004108899A2 (en) 2003-06-04 2004-12-16 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Pni microarray and uses
JP2007518062A (ja) 2003-09-29 2007-07-05 バイオサイト インコーポレイテッド 敗血症を診断する方法および診断するための組成物
JP2005106694A (ja) * 2003-09-30 2005-04-21 Mochida Pharmaceut Co Ltd 敗血症早期検出及び重篤度評価
GB0401730D0 (en) 2004-01-27 2004-03-03 Bioxell Spa Diagnosis method
US8906630B2 (en) 2004-02-27 2014-12-09 The Trustees Of The University Of Pennsylvania Assays for detecting pathogenic respiratory bacteria
US7892539B2 (en) 2004-03-24 2011-02-22 The Regents Of The University Of California Modulation of an innate immune response by altering TRIAL-R signaling
US8155993B2 (en) * 2004-06-15 2012-04-10 Janssen Pharmaceutica, N.V. Apparatus and methods for assessing a pharmaceutical product
JP2008505649A (ja) * 2004-07-09 2008-02-28 アモークス リミテッド 免疫細胞バイオセンサーおよびその使用方法
WO2006023312A2 (en) * 2004-08-20 2006-03-02 Carl Deirmengian Diagnostic assay for source of inflammation
US7572640B2 (en) 2004-09-28 2009-08-11 Singulex, Inc. Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
AU2005290314A1 (en) * 2004-09-28 2006-04-06 Singulex, Inc. System and method for spectroscopic analysis of single particles
EP1807540A4 (en) 2004-11-05 2008-12-10 Us Gov Sec Navy DIAGNOSIS AND PROGNOSIS OF CLINICAL PHENOTYPES OF INFECTION DISEASES AND OTHER PHYSIOLOGICAL CONDITIONS USING GENE EXPRESSION OF A HOSTS AS BIOMARKERS IN THE BLOOD
US20060099628A1 (en) 2004-11-10 2006-05-11 Wei-Mei Ching Diagnostic assay for rickettsia prowazekii disease by detection of responsive gene expression
CN101208602A (zh) 2005-04-15 2008-06-25 贝克顿迪金森公司 脓毒症的诊断
CA2605143A1 (en) 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
US20070015172A1 (en) 2005-06-01 2007-01-18 Z-Biomed, Inc. Expression profiles for microbial infection
UA78641C2 (en) 2005-08-29 2007-04-10 Open Joint Stock Company Conce A process for the preparation of carbamide-formaldehyde resin
DE102005050933A1 (de) 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen
CN101378764A (zh) 2005-12-09 2009-03-04 贝勒研究院 通过血液白细胞微阵列分析对系统性红斑狼疮的诊断、预后和疾病发展的监测
GB0601959D0 (en) 2006-01-31 2006-03-15 King S College London Sepsis test
US20070184460A1 (en) 2006-02-09 2007-08-09 Wei-Mei Ching Diagnostic assay for Orientia tsutsugamushi by detection of responsive gene expression
NZ573052A (en) 2006-04-26 2012-03-30 Vertex Pharma Hepatitis c virus infection biomarkers
RU2348695C2 (ru) * 2006-05-23 2009-03-10 Закрытое акционерное общество "Молекулярно-медицинские технологии" Дифференцирующий и специфический олигонуклеотиды для идентификации последовательностей днк инфекционных агентов в биологических материалах, способ видовой идентификации инфекционных агентов, биочип и набор для осуществления этого способа
AU2007286915B2 (en) 2006-08-11 2014-05-15 Baylor Research Institute Gene expression signatures in blood leukocytes permit differential diagnosis of acute infections
AU2012244350B2 (en) 2006-09-05 2013-08-15 Statens Serum Institut Ip-10 based immunological monitoring
JP5805368B2 (ja) 2006-09-05 2015-11-04 ステイテンス・セラム・インスティテュート Ip−10に基づく免疫学的モニタリング
US20100068147A1 (en) 2006-10-05 2010-03-18 Agency for Science , Technology and Research Dengue diagnosis and treatment
EP2077858A4 (en) 2006-12-06 2011-07-20 Medimmune Llc INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS
DE102006060112A1 (de) 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
WO2008076077A1 (en) 2006-12-21 2008-06-26 Innogene Kalbiotech Pte Ltd Method of early diagnosis of epstein-barr virus-related cancer and respective reagents and kits
AU2008205622A1 (en) 2007-01-11 2008-07-24 Duke University Method of monitoring HIV infection
US8293489B2 (en) 2007-01-31 2012-10-23 Henkin Robert I Methods for detection of biological substances
AU2008220419A1 (en) 2007-02-28 2008-09-04 The Procter & Gamble Company Methods and targets for identifying compounds for regulating rhinovirus infection
DE102007009751A1 (de) 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
MY163053A (en) 2007-06-01 2017-08-15 Council Scient Ind Res A novel method for simultaneous detection and discrimination of bacterial, fungal, parasitic and viral infections of eye and central nervous system
RU2352948C1 (ru) 2007-06-15 2009-04-20 Государственное образовательное учреждение высшего профессионального образования "КРАСНОЯРСКАЯ ГОСУДАРСТВЕННАЯ МЕДИЦИНСКАЯ АКАДЕМИЯ ФЕДЕРАЛЬНОГО АГЕНТСТВА ПО ЗДРАВООХРАНЕНИЮ И СОЦИАЛЬНОМУ РАЗВИТИЮ" Способ прогноза исхода заболевания пациентов с ургентной хирургической патологией органов брюшной полости
IL184478A (en) 2007-07-08 2017-07-31 Hadasit Medical Res Services & Development Ltd Preparations, methods and kits for identifying carriers of mutations in genes 1brca and 2brca and for the early detection of cancers associated with mutations in these genes
DE102007035640A1 (de) 2007-07-27 2009-01-29 Lkh-Kunststoffwerk Gmbh & Co. Kg Tauchkolben
CN103123359B (zh) 2007-08-03 2015-07-29 B.R.A.H.M.S有限公司 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用
EP2020603A1 (en) 2007-08-03 2009-02-04 BRAHMS Aktiengesellschaft Method for risk stratification in stable coronary artery disease
TW200920358A (en) 2007-08-13 2009-05-16 Lundbeck & Co As H Method of treating stress-mediated depression
WO2009025743A2 (en) 2007-08-17 2009-02-26 University Of Massachusetts Medical School Use of trail compositions as antiviral agents
EP2039980B1 (de) 2007-09-24 2010-04-07 BMDSys Production GmbH Kryostat mit stabilisiertem Aussengefäss
EP2071334A1 (en) 2007-12-14 2009-06-17 Transmedi SA Compositions and methods of detecting TIABS
WO2009100907A1 (en) 2008-02-14 2009-08-20 Dianeering Diagnostics Engineering And Research Gmbh Means and methods for assessing the risk of patients presenting to emergency departments based on very low concentrations of troponin i or t or using a combination of markers
WO2009120800A2 (en) * 2008-03-25 2009-10-01 University Of Southern California Prognostic panel for urinary bladder cancer
WO2009130176A1 (en) 2008-04-21 2009-10-29 Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute For Biomedical Research Antiviral Therapy
US9910036B2 (en) 2008-05-20 2018-03-06 Rapid Pathogen Screening, Inc. Method and device for combined detection of viral and bacterial infections
EP2796878A1 (en) 2008-05-23 2014-10-29 Biocartis NV New biomarkers for diagnosis, prediction and/or prognosis of sepsis and uses thereof
AP2011005546A0 (en) 2008-06-25 2011-02-28 Baylor Res Intitute Blood transcriptional signature of mycobacterium tuberculosis infection.
CN102257386B (zh) 2008-10-24 2014-12-31 B.R.A.H.M.S有限公司 通过测定标志肽的水平在已患过中风或短暂性缺血性发作的患者中进行预后和风险评估
GB2463401B (en) 2008-11-12 2014-01-29 Caris Life Sciences Luxembourg Holdings S A R L Characterizing prostate disorders by analysis of microvesicles
US20160041153A1 (en) * 2008-11-12 2016-02-11 Kirk Brown Biomarker compositions and markers
TW201021778A (en) 2008-11-12 2010-06-16 Alcon Res Ltd Intraocular lens delivery device with a multi-part plunger tip
UA92843C2 (ru) 2009-05-21 2010-12-10 Институт Технической Теплофизики Национальной Академии Наук Украины Способ получения порошкообразного пищевого красителя из столовой свеклы
WO2011008349A2 (en) 2009-05-26 2011-01-20 Duke University Methods of identifying infectious disease and assays for identifying infectious disease
EP2438447B1 (en) 2009-06-05 2015-02-18 B.R.A.H.M.S GmbH Detection of bacterial infections in subjects suffering from dyspnea.
EP2462437A4 (en) 2009-08-07 2013-01-30 Rules Based Medicine Inc METHOD AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISEASES THEREOF
JP5667353B2 (ja) * 2009-09-25 2015-02-12 シスメックス株式会社 血球計数装置、診断支援装置、診断支援方法及びコンピュータプログラム
US8383332B2 (en) 2009-10-13 2013-02-26 B.R.A.H.M.S. Gmbh Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack
CA2777800C (en) 2009-10-15 2019-11-12 Crescendo Bioscience Biomarkers and methods for measuring and monitoring inflammatory disease activity
CN102762743A (zh) 2009-12-09 2012-10-31 阿维埃尔公司 用于心血管疾病的诊断和分类的生物标记物检验
US20110312534A1 (en) * 2010-03-05 2011-12-22 Erasmus University Medical Center Rotterdam Method for prediction of human iris color
EP2365456B1 (en) * 2010-03-11 2016-07-20 CompuGroup Medical SE Data structure, method and system for predicting medical conditions
US9709565B2 (en) 2010-04-21 2017-07-18 Memed Diagnostics Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
US20130071866A1 (en) 2010-05-31 2013-03-21 The University Of Tokushima Method for testing the severtiy of an illness
GB2482187A (en) * 2010-07-23 2012-01-25 Univ Exeter Predicting response to surgery
US8877212B2 (en) 2011-02-07 2014-11-04 Trudeau Institute Use of an IL12 receptor-beta 1 splice variant to diagnose active tuberculosis
RU2476887C2 (ru) 2011-03-29 2013-02-27 Учреждение Российской академии медицинских наук Дальневосточный научный центр физиологии и патологии дыхания Сибирского отделения РАМН Способ прогнозирования развития осложнений у больных внебольничной пневмонией
AU2012274461A1 (en) * 2011-06-20 2014-01-16 Kyowa Hakko Kirin Co., Ltd. Anti-erbB3 antibody
US20140329242A1 (en) 2011-09-12 2014-11-06 Thomas M. Aune Characterizing multiple sclerosis
JP5842107B2 (ja) * 2011-10-19 2016-01-13 パナソニックIpマネジメント株式会社 循環動態測定装置
ES2656150T3 (es) 2011-11-14 2018-02-23 Universitätsklinikum Jena Diagnóstico de la sepsis y del síndrome de respuesta inflamatoria sistémica
WO2013119632A1 (en) * 2012-02-07 2013-08-15 Ingber Michael Apparatus and methods for analyzing a medical condition
EP3367099B1 (en) 2012-02-09 2021-05-26 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
EP2637023A1 (en) 2012-03-08 2013-09-11 B.R.A.H.M.S GmbH Prediction of outcome in patients with chronic obstructive pulmonary disease
KR102057132B1 (ko) 2012-03-08 2019-12-18 토멘 메디칼 아게 염증성 조직을 진단하기 위한 치과적 용도의 츄잉검
US9375493B2 (en) * 2012-03-30 2016-06-28 Visen Medical, Inc. Bacterial imaging agents and methods of using same
GB201211982D0 (en) 2012-07-05 2012-08-22 Isis Innovation Biomarker
DK2872891T3 (da) 2012-07-10 2019-05-13 Nepean Blue Mountains Local Health Distr Risikostratificering ved influenza
FR2996003B1 (fr) 2012-09-25 2014-10-17 Commissariat Energie Atomique Methode pour detecter specifiquement dans un echantillon une metalloprotease matricielle (mmp) d'interet uniquement dans sa forme active
US20140127827A1 (en) 2012-11-05 2014-05-08 Gwangju Institute Of Science And Technology Method for detection of antigen using fluorescence resonance energy transfer immunoassay
WO2014085826A2 (en) 2012-11-30 2014-06-05 Applied Proteomics, Inc. Method for evaluation of presence of or risk of colon tumors
US9759721B2 (en) 2013-01-22 2017-09-12 Imicroq, S.L. Rapid method for detection of pathogen
BR112015017954A2 (pt) 2013-01-29 2017-07-11 Molecular Health Gmbh sistemas e métodos para o suporte de decisão clínica
US10689701B2 (en) 2013-03-15 2020-06-23 Duke University Biomarkers for the molecular classification of bacterial infection
WO2014144029A2 (en) * 2013-03-15 2014-09-18 Boston Scientific Neuromodulation Corporation Clinical response data mapping
CN105556308B (zh) 2013-09-20 2018-05-29 阿斯图特医药公司 用于阑尾炎的诊断和预后及腹痛病因的区分的方法和组合物
WO2015048098A1 (en) 2013-09-24 2015-04-02 Washington University Diagnostic methods for infectious disease using endogenous gene expression
BR112017002884A2 (pt) 2014-08-14 2018-01-30 Memed Diagnostics Ltd ?análise computacional de dados biológicos por meio do uso de variedade e hiperplano?
US20170234873A1 (en) 2014-10-14 2017-08-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
EP3221340B1 (en) 2014-11-19 2024-05-22 P & M Venge AB Diagnostic method employing human neutrophil lipocalin (hnl)
CN111624345A (zh) 2014-12-11 2020-09-04 米密德诊断学有限公司 用于诊断多种感染的标记组合及其使用方法
KR20160072626A (ko) 2014-12-15 2016-06-23 전북대학교산학협력단 패혈증 인자 il-6 간이 진단 키트
WO2017072777A1 (en) * 2015-11-01 2017-05-04 Elminda Ltd. Method and system for estimating potential distribution on cortical surface
EP3423590A4 (en) 2016-03-03 2020-02-26 Memed Diagnostics Ltd. DETERMINANTS OF RNA TO DIFFERENTIATE BACTERIAL VIRAL INFECTIONS
IL287757B (en) 2016-03-03 2022-07-01 Memed Diagnostics Ltd Analyzing rna for diagnosing infection type
WO2017221255A1 (en) 2016-06-23 2017-12-28 Memed Diagnostics Ltd. Measuring trail by lateral flow immunoassay
EP3482201B1 (en) 2016-07-10 2022-12-14 Memed Diagnostics Ltd. Early diagnosis of infections
EP3482200B1 (en) 2016-07-10 2022-05-04 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
JP7020689B2 (ja) 2016-09-16 2022-02-16 株式会社オンチップ・バイオテクノロジーズ 微粒子分注装置、微粒子解析装置、及び反応検出装置、並びにそれらを用いる方法
WO2018060999A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of risk assessment and disease classification
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
US10209260B2 (en) 2017-07-05 2019-02-19 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
US12348304B2 (en) 2021-04-08 2025-07-01 Infinidome Ltd. Adjustable null steering in a stationary network

Similar Documents

Publication Publication Date Title
JP2017532633A5 (https=)
RU2017107750A (ru) Вычислительный анализ биологических данных с применением многообразия и гиперплоскости
Stanek et al. A review on mastitis in dairy cows research: Current status and future perspectives
Naccache et al. A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples
Scriba et al. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease
Jung et al. The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease
Skowronski et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009
Skowronski et al. Influenza A/subtype and B/lineage effectiveness estimates for the 2011–2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine
Böszörményi et al. The post-acute phase of SARS-CoV-2 infection in two macaque species is associated with signs of ongoing virus replication and pathology in pulmonary and extrapulmonary tissues
Zhao et al. Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma
Papenburg et al. Genetic diversity and molecular evolution of the major human metapneumovirus surface glycoproteins over a decade
Forero et al. Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells
Mas et al. BRAF mutation status in circulating tumor DNA from patients with metastatic colorectal cancer: extended mutation analysis from the AGEO RASANC study
Woolthuis et al. Long-term adaptation of the influenza A virus by escaping cytotoxic T-cell recognition
Blohmke et al. Diagnostic host gene signature for distinguishing enteric fever from other febrile diseases
Chen et al. Identified three interferon induced proteins as novel biomarkers of human ischemic cardiomyopathy
Mizukami et al. System vaccinology for the evaluation of influenza vaccine safety by multiplex gene detection of novel biomarkers in a preclinical study and batch release test
Fisher et al. Pandemic influenza A H1N1 2009 infection versus vaccination: a cohort study comparing immune responses in pregnancy
Bower et al. Diagnostic criteria schemes for multicentric Castleman disease in 75 cases
Wilson et al. The influenza B virus Victoria and Yamagata lineages display distinct cell tropism and infection-induced host gene expression in human nasal epithelial cell cultures
Moise et al. Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011
Suntronwong et al. Prevalence of antibodies against seasonal influenza A and B viruses among older adults in rural Thailand: A cross-sectional study
Davidson et al. Quantitation of Marek's disease and chicken anemia viruses in organs of experimentally infected chickens and commercial chickens by multiplex real-time PCR
Cui et al. Using multiple linear regression and physicochemical changes of amino acid mutations to predict antigenic variants of influenza A/H3N2 viruses
Lopes et al. Antigenic and genetic diversity of H1 and H3 influenza A viruses in swine in Brazil